RxDoctor Payments Data

Candyce Ackland, MD

Family Medicine · Davenport, IANPI 1255310744

Payments from drug & device makers

$384in general payments, 2019–2025

Across 31 payments — averaging $12.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$214
  • Abbott$49
  • Novo Nordisk$34
  • Lilly USA, LLC$18
  • AstraZeneca$17
  • Amgen$14
  • plus $39 from 3 others

What the payments were for

  • Food & beverage$384100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$384 in reported general payments places this provider in the 70th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$78,383
Medicare patients
121
Services billed
1,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$33,117
JardianceEmpagliflozin21$27,680
FarxigaDapagliflozin Propanediol22$24,196
TrulicityDulaglutide18$22,364
EliquisApixaban18$17,928
Breo ElliptaFluticasone/Vilanterol22$15,217
Spiriva HandihalerTiotropium Bromide11$13,168
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$5,471
LevemirInsulin Detemir13$4,699
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$4,676
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$4,564
Risedronate Sodium26$1,996
Metoprolol Succinate123$1,964
Bisoprolol Fumarate20$1,456
Levothyroxine Sodium159$1,416

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Levemir$34$37,81645 claims
AstraZenecaFarxiga$17$24,19622 claims
Lilly USA, LLCTrulicity$18$22,36418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Davenport

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →